Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
BMS 684 is an inhibitor of diacylglycerol kinase α (DGK-α; IC50 = 0.0046 µM).1 It is selective for DGK-α over DGK-β, -γ, -κ, and -ζ (IC50s = 2.5, 1.9, >10, and >10 µM, respectively), a panel of 327 other kinases at 15 µM, and a panel of 42 receptors, ion channels, and enzymes at 30 µM. BMS 684 induces translocation of DGK-α to the plasma membrane in Jurkat cells (EC50 = 0.52 µM) and increases T cell receptor-mediated IL-2 levels in programmed cell death protein 1-positive (PD-1+) and PD-1- primary human CD4+ T cells.1,2
WARNING This product is not for human or veterinary use.
1. Discovery of potent, dual-
2. DGKα/ζ inhibitors combine with PD-